Association Between Copeptin and Six-Month Neurologic Outcomes in Patients With Moderate Traumatic Brain Injury

BACKGROUND: Copeptin has been reported as a predictive biomarker for the prognosis after traumatic brain injury (TBI). However, most of them were in patients with severe TBI and limited value in predicting outcomes in patients with moderate TBI defined as Glasgow Coma Scale (GCS) score from 9 to 12....

Descripción completa

Detalles Bibliográficos
Autores principales: Jeon, Jin Pyeong, Kim, Seonghyeon, Kim, Tae Yeon, Han, Sung Woo, Lim, Seung Hyuk, Youn, Dong Hyuk, Kim, Bong Jun, Hong, Eun Pyo, Park, Chan Hum, Kim, Jong-Tae, Ahn, Jun Hyong, Rhim, Jong Kook, Park, Jeong Jin, Kim, Heung Cheol, Kang, Suk Hyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081440/
https://www.ncbi.nlm.nih.gov/pubmed/35547639
http://dx.doi.org/10.3389/fneur.2021.749110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081440/
https://www.ncbi.nlm.nih.gov/pubmed/35547639
http://dx.doi.org/10.3389/fneur.2021.749110

Ejemplares similares